Update on the genetics of the fibromyalgia syndrome

Jacob N. Ablin, Dan Buskila

Research output: Contribution to journalReview articlepeer-review


Abstract Fibromyalgia syndrome (FMS), a condition characterized by chronic widespread pain and tenderness, is a complex condition considered to represent a paradigm of centralized pain. FMS has demonstrated a clear familial aggregation, and hence it is considered to have a genetic background. Multiple candidate-gene studies have been conducted in this field, focusing on target genes that play a role in the transmission and processing of pain. While many of these have focused in the past on markers related to neurotransmitter systems such as catecholamines (catechol-O-methyltransferase (COMT)) and serotonin, novel target genes have recently emerged. In addition, genome-wide sequencing scanning (genome-wide association study (GWAS)) is increasingly being harnessed for the study of chronic pain, including FMS. Micro RNAs are another novel field of research related to posttranscriptional inhibition of gene expression, which are currently regarding the pathogenesis of FMS.

Original languageEnglish
Article number1133
Pages (from-to)20-28
Number of pages9
JournalBest Practice and Research in Clinical Rheumatology
Issue number1
StatePublished - 1 Feb 2015


  • Centralized pain
  • Fibromyalgia
  • Neuropathic pain


Dive into the research topics of 'Update on the genetics of the fibromyalgia syndrome'. Together they form a unique fingerprint.

Cite this